神经科

订阅

MedSci主页 / 所有栏目 / 神经科

超全MRI解剖图谱，医生必备！（颅脑）

2016-09-27 qq空间亮亮的小家 qq空间亮亮的小家

核磁共振头部
关注

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (33)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2023-09-08 ms7000001599897175 来自河北省

    清楚，明了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2022-04-06 ting_217

    很好👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2021-07-02 ms9000001925082378

    medsci://medsci.cn

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2020-08-16 人家四月

    感谢感谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-31 1e1263e3m20(暂无匿称)

    很具体形象，收获很大

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-29 李东泽

    这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-19 cjingjuan

    好文章值得学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-19 cjingjuan

    好文章

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-14 李东泽

    很好，不错，以后会多学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2156776, encodeId=fece2156e76ba, content=清楚，明了, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05088840654, createdName=ms7000001599897175, createdTime=Fri Sep 08 21:22:18 CST 2023, time=2023-09-08, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1209039, encodeId=89201209039e3, content=很好👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f79a3020172, createdName=ting_217, createdTime=Wed Apr 06 19:31:44 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995551, encodeId=ed28995551ca, content=medsci://medsci.cn, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210906/9d7bbe88656d4fb7948288632821a188/2263e8388658421688679292e5e11388.jpg, createdBy=02705409116, createdName=ms9000001925082378, createdTime=Fri Jul 02 23:37:05 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809369, encodeId=683080936993, content=感谢感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLMGicvCIibmpTjGP9ib0UbxSZX3WSXfVmatTib7lCsOmic1GP3jiaDuic1YxnR4NFFmYS923pvLKXH0GibdA/132, createdBy=ad235260819, createdName=人家四月, createdTime=Sun Aug 16 14:00:02 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152282, encodeId=f8b51522822d, content=很具体形象，收获很大, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=84e21956153, createdName=1e1263e3m20(暂无匿称), createdTime=Mon Oct 31 00:06:39 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=152013, encodeId=4467152013b9, content=这篇咨询不错哦，值得学习，对于临床工作和科研思路都很有帮助。, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Sat Oct 29 16:17:06 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149693, encodeId=83fc149693d0, content=好文章值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:52 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=149692, encodeId=6bea14969231, content=好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3865018, createdName=cjingjuan, createdTime=Wed Oct 19 09:48:34 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=148306, encodeId=3dbf14830634, content=很好，不错，以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Fri Oct 14 23:12:38 CST 2016, time=2016-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=147132, encodeId=e68a14e13210, content=拜读了，受益匪浅，点个赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Wed Oct 12 18:27:43 CST 2016, time=2016-10-12, status=1, ipAttribution=)]
    2016-10-12 ylzr123

    拜读了，受益匪浅，点个赞！

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

Stroke：六分钟核磁共振成像可用于评价急性缺血性卒中

背景及目的：对于急性缺血性卒中患者的评价，核磁共振成像（MRI）与计算机断层扫描相比，仍需要进一步提高采集速度。方法：此项前瞻、单中心研究的入选标准为急性缺血性卒中发作24h表现出临床症状的患者。美国国立卫生研究院卒中量表≥3，无MRI禁忌症。回波平面成像（EPI）结合平行采集技术用于3T磁共振（MR）扫描以加速收集速度。2位神经系放射专家独立分析图像。结果：62位患者符合入选标准，22位患者接受

Nat Med：核磁共振技术有望用于疟疾快速诊断

近日，发表在 Nature Medicine 杂志上的一项研究称，一台放在桌上的小设备可以通过检测血液中恶性疟原虫生长过程中产生的疟色素（ haemozoin）诊断出疟疾感染。如果该技术能够广泛应用，将有助于偏远地区疟疾的检测和治疗，在这些地方常规的检测手段根本无法发挥作用。 常规检测手段 诊断疟疾感染的常规方法是通过显微镜在患者的血液样本中寻找导致该疾病的恶性疟原虫。这种方法需要一名

Radiology：核磁共振”背景强化“检查可预测女性患乳腺癌风险

我们都知道，常规核磁共振(MRI)检查有助于诊断乳腺癌。不仅如此，一项最新研究发现,MRI检查还有助于女性预测日后患乳腺癌风险。 华盛顿大学医学院的研究人员、放射学家Habib Rahbar发现，高乳腺癌风险女性MRI扫描后，呈现其共有特点——乳腺组织背景区域呈现高亮白色，这种现象在核磁共振技术领域术语称为“背景强化”（background parenchymal enhancement,

Ann Rheum Dis：椎角炎症和椎角脂肪沉积都有助于强直性柱炎的新骨生成

目标：研究在同一椎体角MRI椎角炎症（VCI）、椎角脂肪沉积（VCFD）和骨赘成长射线的时序关系。方法：在基线、24周和102周时予核磁共振检测，观察I椎角炎症（VCI）和椎角脂肪沉积（VCFD）的发生与缺失。另外，检测颈椎与腰椎脊柱角前部的侧位X片（基线与102周），以评估新骨的发展（骨赘形成或骨赘形成/增长）。使用以上两种方法和多层次分析161-177例病人的脊柱角数据，调整病人的内相关因素和

核磁共振T1与T2区别，读片必知 ！

磁共振成像是利用原子核在磁场内共振产生的信号经重建成像的成像技术。人体组织中的原子核(含基数质子或中子，一般指氢质子)在强磁场中磁化，梯度场给予空间定位后，射频脉冲激励特定进动频率的氢质子产生共振，接受激励的氢质子驰豫过程中释放能量，即磁共振信号，计算机将MR信号收集起来，按强度转换成黑白灰阶，按位置组成二维或三维的形态，最终组成MR图像。T1加权像、T2加权像为磁共振检查中报告中常提到的术语，很

JACC：植入式心律转复除颤器患者的全身磁共振成像

背景：常规植入式心脏除颤器（ICD）的患者禁止进行磁共振成像（MRI）。    意义：这项多中心的随机试验评估了专门为全身的MRI设计的，不会对心脏速率或起搏依赖限制的一个新颖的ICD系统的安全性和有效性。主要安全目标是MRI30天后无MRI相关事件复合终点＞90％。主要疗效终点为心室起搏阈值和心室感知幅度。    方法：受试者接受单腔或